Skip links

Author: oncologs.com

Functional information offers individualized adaptive cancer therapies

BUFFALO, NY- August 30, 2024 – A new editorial was published in Volume 11 of Oncoscience on July 19, 2024, entitled, “Functional information offers individualized adaptive cancer therapies.” Credit: Impact Journals, LLC BUFFALO, NY- August 30, 2024 – A new editorial was published in Volume

Researchers map 50,000 of DNA’s mysterious ‘knots’ in the human genome

DNA is well-known for its double helix shape. But the human genome also contains more than 50,000 unusual ‘knot’-like DNA structures called i-motifs, researchers at the Garvan Institute of Medical Research have discovered. Credit: Garvan Institute Researchers map 50,000 of DNA’s mysterious ‘knots’ in the

Dine on DNA: Compounds from nucleic acids in food show anticancer effects

When people eat, they ingest the nucleic acids that reside in all living things. The compounds in these acids could inhibit the growth of cancer cells, according to findings published in PLOS ONE by Osaka Metropolitan University Associate Professor Akiko Kojima-Yuasa of the Graduate School

Innovations in cancer treatment through targeted bacterial vaccines

The human body hosts more than 1014 bacteria, which play crucial roles in human health. F. nucleatum, an oral anaerobe, is frequently associated with colorectal cancer and is linked to increased cancer cell proliferation, metastasis, and poor treatment outcomes. Recent studies have shown that F.

Common salt activates anti-tumor cells

Sodium chloride, commonly known as “table salt”, was a valuable commodity in history. Today, table salt is cheap and indispensable in the kitchen. It is therefore not surprising that it has long since found its way into our everyday language – although not all expressions

miR-10b Inhibition: A strategy for treating metastatic breast cancer

“We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” Credit: Halim et al. “We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” BUFFALO, NY- August 28, 2024 – A new research paper was
Explore
Drag